SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 30.42-1.1%Nov 13 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Crovelli who wrote (28)9/10/1996 6:15:00 PM
From: Gerald Thomas   of 455
 
A couple of things..
I've owned this stock close to a year now and I'm waiting for
the results of the trials like everyone else.
But in the middle of July a "brief " was filed during the national aids conference
and an article in a dow jones text file summarized that
an initial trial of healthy (hiv negative) subjects
was conducted to test the safety of the single injection protocal.
evidently the protocal was well tollerated during that period
(I dont have the exact words)
and I'm assuming the length of the trial is because the second half was
to test the effectiveness of the protocal.
yesterday, the news was that the R&D is being cut by I believe 30%
to concentrate on the current trials ;including finding sponsors for
for the various drug candidates
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext